Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)

ClinicalTrials.gov ID: NCT06057012

Public ClinicalTrials.gov record NCT06057012. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Descriptive Efficacy of BRII-296 in Adults With Severe Postpartum Depression (PPD)

Study identification

NCT ID
NCT06057012
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Brii Biosciences Limited
Industry
Enrollment
11 participants

Conditions and interventions

Interventions

  • BRII-296 Drug
  • Depo Medrol Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2023
Primary completion
Mar 12, 2024
Completion
Mar 12, 2024
Last update posted
Jan 26, 2025

2023 – 2024

United States locations

U.S. sites
11
U.S. states
5
U.S. cities
10
Facility City State ZIP Site status
Cenexel CNR Sherman Oaks California 91403
CenExel CNS-Torrance Torrance California 90504
Clinical Research Center of Florida Boynton Beach Florida 33435
Aventura Clinical Research, LLC Davie Florida 33328
South Florida Research Phase I-IV Inc Miami Springs Florida 33166
Synexus Clinical Research US, Inc. Atlanta Georgia 30328
Cenexel ACMR Atlanta Center for Medical Research Atlanta Georgia 30331
iResearch Atlanta, LLC Decatur Georgia 30030
Research Carolina Elite Denver North Carolina 28037
North Texas Clinical Trials Fort Worth Texas 76104
Maximos OB/GYN League City Texas 77573

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06057012, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06057012 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →